Connor, Clark & Lunn Investment Management (CC&L)
NVLN

Connor, Clark & Lunn Investment Management (CC&L)’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
2017
Q2 		$108K Sell
2017
Q1 		$615K Sell
2016
Q4 		$1.42M Buy